Earlier this week President Trump and the CEO's of the nation's largest pharmaceutical companies met at the White House. Media reports of the discussion were limited to a few generalities about tax reductions, deregulation and lower prices. The actual conversation was much more interesting. Here is an insider's report.
Posted in Trend Arenas